Soper v. Chipotle Mexican Grill of Colorado, LLC

CourtDistrict Court, S.D. Georgia
DecidedJuly 12, 2022
Docket4:20-cv-00324
StatusUnknown

This text of Soper v. Chipotle Mexican Grill of Colorado, LLC (Soper v. Chipotle Mexican Grill of Colorado, LLC) is published on Counsel Stack Legal Research, covering District Court, S.D. Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Soper v. Chipotle Mexican Grill of Colorado, LLC, (S.D. Ga. 2022).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF GEORGIA SAVANNAH DIVISION

KAYLA SOPER, ) ) Plaintiff, ) ) v. ) CV420-324 ) CHIPOTLE MEXICAN GRILL ) OF COLORADO, LLC, ) ) Defendant. )

ORDER Before the Court is Defendant Chipotle Mexican Grill of Colorado, LLC’s (“Chipotle”) Motion to Exclude Opinion Testimony of Plaintiff Kayla Soper’s Expert Witness Dr. Michael Freeman. Doc. 27. Soper responded in opposition, doc. 32, and Chipotle replied, doc. 37. For the following reasons, Chipotle’s motion is GRANTED. Doc. 27. BACKGROUND Soper’s Complaint alleges that she suffered vomiting, diarrhea, and an eventual skin infection after dining at a Chipotle restaurant with her son and mother. Doc. 1-3 at 6-7. She shared a meal with her son at the restaurant, and her mother had a different meal. Id. at 6. That evening, her son “became violently ill with diarrhea and vomiting.” Plaintiff subsequently experienced the same symptoms. Id. She noticed “an abscess in her rectal area” five days after the meal, id., and a surgeon

diagnosed her with a necrotizing soft tissue infection.1 See doc. 29-9 at 16-17.

Soper identified Freeman as a retained expert in forensic medicine and epidemiology. Doc. 27-4 at 3; see also Fed. R. Civ. P. 26(a)(2)(B). He testifies that the most likely cause of both Soper’s initial gastrointestinal

symptoms, i.e., the vomiting and diarrhea, and her subsequent skin infection, is her consumption E. coli-contaminated food at Chipotle. See, e.g., doc. 29-2 at 222-23. Chipotle argues that the Court should exclude

his testimony because he is not qualified to render medical causation opinions, his methodology is unreliable, and his opinions “will not assist the trier of fact[.]” Doc. 27-1 at 2.

ANALYSIS Federal Rule of Evidence 702 compels the Court to act as a “gatekeeper” for expert evidence. United States v. Frazier, 387 F.3d 1244,

1260 (11th Cir. 2004) (citing Daubert v. Merrell Dow Pharms., Inc., 509

1 Freeman refers to the infection as necrotizing fasciitis in his report and deposition. See generally doc. 29-2. The Court will refer to the condition as the “skin infection.” U.S. 579, 589 n. 7, 597 (1993)). In performing this task, the Court must consider whether the party offering the evidence has shown:

(1) the expert is qualified to testify competently regarding the matters he intends to address; (2) the methodology by which the expert reaches his conclusions is sufficiently reliable as determined by the sort of inquiry mandated in Daubert; and (3) the testimony assists the trier of fact, through the application of scientific, technical, or specialized expertise, to understand the evidence or to determine a fact in issue.

Frazier, 387 F.3d at 1260 (quoting City of Tuscaloosa v. Harcros Chems., Inc., 158 F.3d 548, 562 (11th Cir.1998)). The proponent of the expert opinion bears the burden of establishing qualification, reliability, and helpfulness by a preponderance of the evidence. Allison v. McGhan Med. Corp., 184 F.3d 1300, 1306 (11th Cir. 1999) (citing Daubert, 509 U.S. at 592 n.10). Under the first prong, “experts may be qualified in various ways. While scientific training or education may provide possible means to qualify, experience in a field may offer another path to expert status.” Frazier, 387 F.3d at 1260–61; see also Fed. R. Evid. 702 (a witness may

be qualified as an expert by “knowledge, skill, experience, training, or education[.]”). But, “[w]hen an expert witness relies mainly on experience to show he is qualified to testify, ‘the witness must explain how that experience leads to the conclusion reached, why that experience is a sufficient basis for the opinion, and how that experience is reliably

applied to the facts.’ ” Payne v. C.R. Bard, Inc., 606 F. App'x 940, 942-43 (11th Cir. 2015.) (quoting Frazier, 387 F.3d at 1261).

As to the second prong, the reliability “criterion remains a discrete, independent, and important requirement for admissibility.” Frazier, 387 F.3d at 1261. “The Supreme Court in Daubert set out a list of ‘general

observations’ for determining whether expert testimony is sufficiently reliable to be admitted under Rule 702.” United States v. Brown, 415 F.3d 1257, 1267 (11th Cir. 2005) (citation omitted). These factors, or

observations, inquire into the expert's “theory or technique” and are: “(1) whether it can be (and has been) tested; (2) whether it has been subjected to peer review and publication; (3) what its known or potential rate of

error is, and whether standards controlling its operation exist; and (4) whether it is generally accepted in the field.” Id. (citation omitted). “Sometimes the specific Daubert factors will aid in determining

reliability; sometimes other questions may be more useful.” Frazier, 387 F.3d at 1262. “Indeed, the Committee Note to the 2000 Amendments of Rule 702 expressly says that, ‘[i]f the witness is relying solely or primarily on experience, then the witness must explain how that experience leads to the conclusion reached, why that experience is a sufficient basis for the

opinion, and how that experience is reliably applied to the facts.’ ” Id. at 1261.

Lastly, expert testimony must assist the trier of fact. Frazier, 387 F.3d at 1262. “By this requirement, expert testimony is admissible if it concerns matters that are beyond the understanding of the average lay

person.” Id. (citation omitted). This inquiry is commonly called the “helpfulness” inquiry. Prosper v. Martin, 989 F.3d 1242, 1249 (11th Cir. 2021) (citing Frazier, 387 F.3d at 1260). “Expert testimony which does

not relate to any issue in the case is not relevant and, ergo, non-helpful.” Id. (quoting Daubert, 509 U.S. at 591). Dr. Freeman’s report explains that he applied a three-step

“causation analysis”: 1) Whether the investigated exposure had the potential to cause the disease in question (general causation), and if known, the magnitude of that potential (risk); 2) The degree of temporal proximity between the exposure and the onset of the symptoms reasonably indicating the presence of the illness; and 3) Whether there is a more likely alternative explanation for the occurrence of the illness at the same point in time, versus the investigated exposure (also known as a differential etiology/ diagnosis). This alternative or competing cause is quantified for the individual, given their predictive characteristics and the temporal relationship quantified in [S]tep 2.

Doc. 29-2 at 209. The “differential etiology/ diagnosis” described in the third step is “a scientific technique where the expert identifies the cause of a medical problem by ‘eliminating the likely causes until the most probable one is isolated.’ ” Longoria v. Ethicon, Inc., 2020 WL 7238151, at *2 (M.D. Fla. Dec. 9, 2020) (quoting In re C.R. Bard, Inc., 948 F. Supp.

2d 589, 602 (S.D.W. Va. 2013)). “When properly conducted, a differential diagnosis can be a reliable methodology under Daubert.” Guinn v. AstraZeneca Pharm. LP, 602 F.3d 1245, 1253 (11th Cir. 2010). It “need

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Guinn v. ASTRAZENECA PHARMACEUTICALS LP
602 F.3d 1245 (Eleventh Circuit, 2010)
United States v. Richard Junior Frazier
387 F.3d 1244 (Eleventh Circuit, 2004)
United States v. Ronald Keith Brown
415 F.3d 1257 (Eleventh Circuit, 2005)
Hendrix Ex Rel. Gp v. Evenflo Co., Inc.
609 F.3d 1183 (Eleventh Circuit, 2010)
Anthony Payne v. C.R. Bard, Inc.
606 F. App'x 940 (Eleventh Circuit, 2015)
Edeline Julmisse Prosper v. Anthony Martin
989 F.3d 1242 (Eleventh Circuit, 2021)
Westberry v. Gislaved Gummi AB
178 F.3d 257 (Fourth Circuit, 1999)
Jones v. Novartis Pharmaceuticals Corp.
235 F. Supp. 3d 1244 (N.D. Alabama, 2017)
Clausen v. M/V New Carissa
339 F.3d 1049 (Ninth Circuit, 2003)
In re C.R. Bard, Inc.
948 F. Supp. 2d 589 (S.D. West Virginia, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
Soper v. Chipotle Mexican Grill of Colorado, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/soper-v-chipotle-mexican-grill-of-colorado-llc-gasd-2022.